The Imaging Core will perform all MR and bioluminescence imaging studies on mouse tumor models for Projects 1 and 2. In addition, the Imaging Core is responsible for all preclinical and clinical data archiving, post-processing and analysis. Core personnel will provide services including: (a) define and implement data acquisition/imaging sequences;(b) assist with animal preparation for imaging;(c) perform all data collection on the 9.4 Tesla MRI, 7 Tesla MRI and Caliper bioluminescence imaging systems;(d) preliminary data processing/image reconstruction and quantitative analysis including PRM analysis for both preclinical (Projects 1 and 2) and clinical imaging data (Project #3) and outcomes data;(e) secure archival of raw data and network transfer of reconstructed data from off-site facilities;(f) scheduling of imaging experiments;and (g) provide support to Program Investigators in technical design and implementation of imaging experiments. These services are designed, in part, after a "clinical MRI service" model since continual, high-volume animal scanning is essential for the success of each project Specific animal MRI protocols will vary with each project, but will primarily include serial studies using: standard T2-weighted;Tl-weighted dynamic contrast enhanced;multislice quantitative water diffusion mapping and dynamic contrast enhancing permeability mapping. The Core will also facilitate the identification of the spatial coordinates needed for biopsy of mouse gliomas using stereotaxic procedures and facilite this activity. The Core will also assist with transfer of MR data to Imbio, LLC for offsite analysis of diffusion and perfusion MRI data sets acquired at multiple sites. Dr. Galban will serve as Core B Director. Dr. Galban has extensive experience in small animal imaging research as well as digital image processing and analysis of clinical MRI data. A Co-investigator and staff will assist Dr. Galban with adapting image processing algorithm's and associated analysis software to ensure the needs of this programmatic research effort are fully met.

Public Health Relevance

Overall, this research effort will provide the imaging data and analysis for evaluating improved approaches including the use of molecularly targeted therapies for the treatment of malignant brain tumors. Additionally, imaging biomarkers for early assessment of treatment response and recurrence will be identified and validated which will lead to individualization of patient care.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-W)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Boes, Jennifer L; Hoff, Benjamin A; Bule, Maria et al. (2015) Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS). Acad Radiol 22:186-94
Leder, Kevin; Pitter, Ken; Laplant, Quincey et al. (2014) Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell 156:603-16
Tsien, Christina; Cao, Yue; Chenevert, Thomas (2014) Clinical applications for diffusion magnetic resonance imaging in radiotherapy. Semin Radiat Oncol 24:218-26
Nazem-Zadeh, Mohammad-Reza; Chapman, Christopher H; Chenevert, Thomas et al. (2014) Response-driven imaging biomarkers for predicting radiation necrosis of the brain. Phys Med Biol 59:2535-47
Berezovsky, Artem D; Poisson, Laila M; Cherba, David et al. (2014) Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Neoplasia 16:193-206, 206.e19-25
Chenevert, Thomas L; Malyarenko, Dariya I; Newitt, David et al. (2014) Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. Transl Oncol 7:65-71
Weber, Thomas G; Osl, Franz; Renner, Anja et al. (2014) Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively. Cancer Res 74:1913-23
Boes, Jennifer L; Hoff, Benjamin A; Hylton, Nola et al. (2014) Image registration for quantitative parametric response mapping of cancer treatment response. Transl Oncol 7:101-10
Galbán, Craig J; Boes, Jennifer L; Bule, Maria et al. (2014) Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:1592-8
Galban, Stefanie; Jeon, Yong Hyun; Bowman, Brittany M et al. (2013) Imaging proteolytic activity in live cells and animal models. PLoS One 8:e66248

Showing the most recent 10 out of 102 publications